| Mary Edwards, PHARMD | |
|
12880 Airline Hwy, Baton Rouge, LA 70817-5105 | |
| (225) 751-3611 | |
| Not Available |
| Full Name | Mary Edwards |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12880 Airline Hwy, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033827563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PST.024613 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Edwards, PHARMD 16333 Columns Way Apt 8204, Baton Rouge, LA 70817-7749 Ph: (910) 922-1274 | Mary Edwards, PHARMD 12880 Airline Hwy, Baton Rouge, LA 70817-5105 Ph: (225) 751-3611 |
News Archive
Kaiser Health News staff writers Phil Galewitz and Mary Agnes Carey write about a term that will be central to how health reform is implemented: "Under the law, existing, or 'grandfathered' health plans are exempt from several consumer protections, including a requirement that beginning as early as September prohibits health plans from charging co-payments
Philadelphia-based Living Beyond Breast Cancer, the national information and support organization, has opened registration for its ninth annual conference for women living with metastatic breast cancer. The event takes place Saturday, April 11 – Sunday April 12, 2015 at the Loews Philadelphia Hotel in Philadelphia, Pennsylvania.
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company's potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI's plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.
In the first analysis of its kind, UC San Francisco research shows that emergency department closures can have a ripple effect on patient outcomes at nearby hospitals.
› Verified 3 days ago
Mr. Kenneth W. Howie, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7515 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-6084 Fax: 225-767-7300 | |
Mrs. Sharon Ann Alcorn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4485 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-926-0734 | |
Sonya Bremer Boss, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3239 Riverwalk Dr, Baton Rouge, LA 70820 Phone: 225-281-1475 Fax: 225-578-7163 | |
Norman Francise, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 | |
Paul Antoine Bordelon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6920 Plank Rd, Baton Rouge, LA 70811 Phone: 225-356-0654 | |
Ms. Jennifer Leane Simpson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 Fax: 225-261-1622 | |
Charles Joseph Paradelas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7411 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-928-8982 Fax: 225-928-8986 |